Disclosure 0001193125-26-365116-3

SEC FORM 4

$94,076.75

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Sale of 2,500 shares at $37.6307 per share.

Reporting Person Weiss Amir · Officer Title Chief Accounting Officer · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001193125-26-365116 · filed 2026-08-25 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)." Disclosed 2026-08-25. https://desqlong.com/cards/0001193125-26-365116-3 (retrieved 2026-09-26).